These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 26866747)

  • 21. [The relationship between sleep quality and glucose level, diabetic complications in elderly type 2 diabetes mellitus].
    Jin QH; Chen HH; Yu HL; Li TL
    Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):357-61. PubMed ID: 22883333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast.
    Zargar AH; Siraj M; Jawa AA; Hasan M; Mahtab H
    Int J Clin Pract; 2010 Jul; 64(8):1090-4. PubMed ID: 20455956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 25. [Correlation between TCF7L2 gene polymorphism and genetic susceptibility in women with gestational diabetes mellitus].
    Shi X; Cai Q; Zou M; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):588-93. PubMed ID: 25354859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gliclazide in the treatment of obese non-insulin dependent diabetic patients.
    Seshiah V; Venkataraman S; Suresh K
    J Assoc Physicians India; 1993 Jun; 41(6):367-8. PubMed ID: 8005974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the
    Dianatshoar D; Alidaee T; Sarhangi N; Afshari M; Aghaei Meybodi HR; Hasanzad M
    J Diabetes Metab Disord; 2022 Jun; 21(1):133-139. PubMed ID: 35673510
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Shakerian S; Rashidi H; Birgani MT; Saberi A
    J Diabetes Metab Disord; 2022 Jun; 21(1):33-41. PubMed ID: 35673481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics of sulfonylureas in type 2 diabetes mellitus; a systematic review.
    Karkhaneh L; Tabatabaei-Malazy O; Bandarian F; Mohseni S; Larijani B
    J Diabetes Metab Disord; 2022 Jun; 21(1):863-879. PubMed ID: 35673432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes.
    Zeng Z; Huang SY; Sun T
    Diabetes Ther; 2020 Nov; 11(11):2521-2538. PubMed ID: 32930968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.
    Anfinogenova Y; Grakova EV; Shvedova M; Kopieva KV; Teplyakov AT; Popov SV
    Heart Fail Rev; 2018 May; 23(3):481-497. PubMed ID: 28849410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes.
    Li Q; Tang TT; Jiang F; Zhang R; Chen M; Yin J; Bao YQ; Cheng X; Hu C; Jia WP
    Acta Pharmacol Sin; 2017 Jan; 38(1):80-89. PubMed ID: 27694910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CYP2C93 variant is associated with antidiabetes efficacy of gliclazide in Chinese type 2 diabetes patients.
    Zeng W; Guo Y; Chen P; Liu Z; Chen D; Han C
    J Diabetes Investig; 2016 Sep; 7(5):764-8. PubMed ID: 27181593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of early intensive therapy on islet beta cell function and long-term glycemia control in newly diagnosed type 2 diabetic patients with different fasting plasma glucose levels.].
    Li YB; Zeng LY; Shi LX; Zhu DL; Zhou ZG; Yan L; Tian HM; Luo ZJ; Yang LY; Liu J; Weng JP
    Zhonghua Nei Ke Za Zhi; 2010 Jan; 49(1):9-13. PubMed ID: 20356473
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Erfani T; Sarhangi N; Afshari M; Abbasi D; Meybodi HRA; Hasanzad M
    J Diabetes Metab Disord; 2020 Jun; 19(1):47-51. PubMed ID: 32550155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of KCNQ1 polymorphisms with gliclazide efficacy in Chinese type 2 diabetic patients.
    Duan F; Guo Y; Zhang L; Chen P; Wang X; Liu Z; Hu Y; Chen S; Chen D
    Pharmacogenet Genomics; 2016 Apr; 26(4):178-183. PubMed ID: 26866747
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.